Ji-young Song

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications

FusionTarget: Computational framework for drug repurposing against modeled fusion protein structures from genomic breakpoints.

FusionTarget: Computational framework for drug repurposing against modeled fusion protein structures from genomic breakpoints.

Journal: iScience
Published: July 22, 2025

Correction: c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer.

Correction: c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer.

Journal: Breast cancer research : BCR
Published: January 08, 2025

Real-time assessment of relative mitochondrial ATP synthesis response against inhibiting and stimulating substrates (MitoRAISE).

Real-time assessment of relative mitochondrial ATP synthesis response against inhibiting and stimulating substrates (MitoRAISE).

Journal: Cancer & metabolism
Published: April 09, 2024

HER3 overexpression: a predictive marker for poor prognosis in advanced ALK-positive non-small cell lung cancer treated with ALK inhibitors.

HER3 overexpression: a predictive marker for poor prognosis in advanced ALK-positive non-small cell lung cancer treated with ALK inhibitors.

Journal: Translational lung cancer research
Published: December 03, 2023

Detection of EGFR exon 20 insertion mutations in non-small cell lung cancer: implications for consistent nomenclature in precision medicine.

Detection of EGFR exon 20 insertion mutations in non-small cell lung cancer: implications for consistent nomenclature in precision medicine.

Journal: Pathology
Published: October 06, 2023

c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer.

c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer.

Journal: Breast cancer research : BCR
Published: May 30, 2023

Cancer-Specific Sequences in the Diagnosis and Treatment of NUT Carcinoma.

Cancer-Specific Sequences in the Diagnosis and Treatment of NUT Carcinoma.

Journal: Cancer research and treatment
Published: July 01, 2022

Overexpression of the NEK9-EG5 axis is a novel metastatic marker in pathologic stage T3 colon cancer.

Overexpression of the NEK9-EG5 axis is a novel metastatic marker in pathologic stage T3 colon cancer.

Journal: Scientific reports
Published: June 27, 2022

Unearthing novel fusions as therapeutic targets in solid tumors using targeted RNA sequencing.

Unearthing novel fusions as therapeutic targets in solid tumors using targeted RNA sequencing.

Journal: Frontiers in oncology
Published: March 09, 2022

Analysis of PIK3CA Mutation Concordance and Frequency in Primary and Different Distant Metastatic Sites in Breast Cancer.

Analysis of PIK3CA Mutation Concordance and Frequency in Primary and Different Distant Metastatic Sites in Breast Cancer.

Journal: Cancer research and treatment
Published: January 02, 2022

A Polytherapy Strategy Using Vincristine and ALK Inhibitors to Sensitise EML4-ALK-Positive NSCLC.

A Polytherapy Strategy Using Vincristine and ALK Inhibitors to Sensitise EML4-ALK-Positive NSCLC.

Journal: Cancers
Published: December 10, 2021

Implant complications in bruxism patients.

Implant complications in bruxism patients.

Journal: Journal of the Korean Association of Oral and Maxillofacial Surgeons
Published: March 29, 2021
Showing 1-12 of 47

Last Updated: 09/26/2026